Insys Therapeutics Reports Listing of US Patents Covering SUBSYS Use, Formulation in FDA's Orange Book

Insys Therapeutics, Inc. (NASDAQ: INSY ), a pharmaceutical company focused on commercial-stage specialty pharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has listed U.S. Patent Nos. 8,486,972 ('972 patent) and 8,486,973 ('973 patent) in its Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. Both of these patents cover SUBSYS brand